Dr. Sushant Khanal is a Scientist in the Research and Development department at Covaris, a position he has held since January 2023. His academic background includes a Ph.D. in Biomedical Sciences with a focus on infectious diseases, inflammation, and immunology from East Tennessee State University (2022), an M.S. in Biology (Microbiology) from the same institution (2017), and a B.S. in Biotechnology from Purbanchal University, Nepal (2014). Before joining Covaris, Dr. Khanal developed extensive expertise in molecular microbiology and immunology, with a significant publication record in viral pathogenesis, particularly related to HIV, HBV, and COVID-19, and CRISPR/Cas9 gene editing. In his current role, he applies this deep molecular biology knowledge to the design, development, and launch of next-generation sequencing (NGS) and whole-genome sequencing (WGS) library preparation products.